HealthQuill Articles by: HealthQuill
Drugs Health Medical

Exercise, a promising approach to tackle postpartum depression

HQ Team November 30, 2023: Postpartum depression is a common psychological affliction following childbirth and affects 17.22% of the world population. Postpartum depression

Read More
The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023 was received with surprise by many. Compared to cereals like rice and wheat, millets were not given much significance and now they are considered as super food with high nutritive value.
Drugs Health Pharma

Opinion: Feast for G20 leaders, benefits of millets exceed rice, wheat

By Dr. K. Leelamoni November 30, 2023: The move to serve Indian millet-based food, to G20 leaders in New Delhi in September 2023

Read More
The first human case of a new swine flu variant in the UK has been detected by the Health Security Agency during a polymerase chain reaction testing after the individual had respiratory illness.
Drugs Health Pharma

First new strain of swine flu detected in UK, probe on to track virus origins

HQ Team November 29, 2023: The first human case of a new swine flu variant in the UK has been detected by the

Read More
The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global health agency reported an 8.9% rise in global prevalence in cases arising in the UK, France and Sweden.
Drugs Health Pharma

Omicron mutant BA.2.86 reclassified as ‘variant of interest’ by WHO 

HQ Team November 29, 2023: The WHO has reclassified the Covid-19 virus Omicron BA.2.86 mutation as a “variant of interest” after the global

Read More
The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies in patients who received treatment.
Drugs Health Pharma

FDA probing T cell cancer therapies of Gilead Sciences, Novartis, J & J

HQ Team November 29, 2023: The USFDA is probing cancer therapies of Gilead Sciences, Johnson & Johnson and Novartis following reports of malignancies

Read More
The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory at the Milner Therapeutics Institute
Drugs Health Pharma

Cambridge Univ, AstraZeneca, MRC to set up genomics laboratory

HQ Team November 29, 2023: The University of Cambridge announced a partnership with AstraZeneca and the Medical Research Council to set up a functional genomics laboratory

Read More
The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization currently chaired by China for the standardization of medical devices, due to a divergence of views.
Drugs Medical Pharma

FDA pulls out of 33-member medical devices body as differences emerge

HQ Team November 28, 2023: The USFDA has officially pulled out of its membership of the Global Harmonization Working Party (GHWP), an organization

Read More
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Medical Pharma

Eli Lilly’s Zepbound outperforms Novo’s Wegovy in weight loss study

HQ team November 28, 2023: A recent comparative analysis of Eli Lilly and Novo Nordisk’s weight loss drugs on diabetes patients showed Eli

Read More
Eli Lilly’s Alzheimer’s experimental drug, donanedab, slowed down cognitive and functional decline in people with early symptoms of the disease, according to a company statement.
Drugs Medical Pharma

Argenx’s Vyvgart faces setback in autoimmune treatment trial

HQ Team November 28, 2023: Argenx SE, a Belgian biopharmaceutical announced that its experimental drug Vyvgart Hytrulo failed in trials in treating immune

Read More
Alembic FDA nod
Climate Health Pharma

Environment, lifestyle behind epidemic of autoimmune diseases

HQ Team November 28, 2023: An escalating global crisis is unfolding as an increasing number of individuals grapple with autoimmune diseases, conditions wherein

Read More